Hemangioma of Bone

Demographics

Pathogenesis

Asymptomatic Hemangioma (95%)

Symptomatic Hemangioma (Less than 1%)

Physical Examination

The topic calls preoperative embolization "essential" and lists it in almost every management pathway, and its own Controversies note that "radicular feeders raise spinal-cord-infarction concerns" - but the procedural safety that underlies this is never developed, and it is the single most important thing to know before embolizing a thoracolumbar vertebral hemangioma. (The cord's arterial anatomy itself is covered in the spinal-cord-blood-supply topic; this is the embolization-procedure nuance.)

• The danger is a shared radiculomedullary feeder. The segmental (intercostal/lumbar) arteries that supply a vertebral hemangioma can also give off a radiculomedullary branch to the anterior spinal artery - in the lower thoracic/upper lumbar spine this is the artery of Adamkiewicz (arteria radicularis magna, usually left, T9-L2). Embolic material that passes into that branch causes anterior spinal artery infarction and paraplegia - the catastrophic complication of spinal tumour embolization.
• How the risk is minimised. Embolization is done by superselective microcatheterisation of the tumour's feeding pedicles, with careful pre-embolization angiography (and provocative testing where indicated) to confirm that the vessel about to be embolized does not supply the cord; the particle size is chosen large enough not to pass through arteriovenous shunts into the cord or lungs; and the operator stops if a radiculomedullary/cord feeder is identified. Liquid agents and ethanol (alcohol) are powerful but higher-risk (reflux, cord infarction, skin necrosis, cardiovascular effects), so they are used cautiously.
• Timing and purpose. Particulate transarterial embolization is performed 24-48 hours before surgery (not the same day) so the tumour bed thromboses and intraoperative blood loss falls; it is also used as a stand-alone or vertebroplasty-adjunct treatment for painful non-compressive lesions.

The topic recommends vertebroplasty/kyphoplasty across its pain pathways and lists "cement extravasation" as a complication, but never explains why a hemangioma is uniquely dangerous to cement - a high-yield point that also explains why alcohol/embolization is often done first.

• The lesion is plumbed into the epidural veins. A hemangioma's dilated intraosseous vascular channels communicate directly with the basivertebral vein and the valveless epidural and paravertebral venous plexus (Batson's plexus). Injecting PMMA cement into this high-flow vascular space therefore risks the cement tracking into the epidural space (cord/root compression) or embolizing through the veins to the lungs (pulmonary cement embolism) - a greater risk than in an ordinary osteoporotic fracture.
• Reduce the flow before you inject. This is the rationale for pre-procedural sclerosis/embolization (transarterial particles or intralesional alcohol) before cement in an aggressive or epidural-extending hemangioma - occluding the vascular channels first lowers the leak risk and improves the durability shown in the alcohol-embolization-plus-vertebroplasty series.
• Inject safely. Use higher-viscosity cement injected slowly under continuous ("live") biplane/lateral fluoroscopy, and stop at the first sign of posterior or venous filling; a kyphoplasty balloon cavity can allow a more controlled, lower-pressure fill. The goal is pain relief and stabilisation, not complete filling.

Complications

Prognosis

Global Epidemiology

• Most common benign vascular tumour of bone; found in 10-12% of spines at autopsy worldwide
• Vertebral body (28-30%) and calvarium (about 20%) are the dominant sites; thoracic spine predominates
• Peak detection 4th-5th decades, female-to-male ratio about 2:1 (up to 3:1 for vertebral lesions)
• Under 1% of all hemangiomas ever become symptomatic, and progression of an incidental lesion is rare (2 of 59 over a mean 7.4 years in the Mayo series)

Side-by-Side Guidance

Bone hemangioma has no single dedicated society guideline; recommendations are derived from tumour-classification bodies and spine-oncology consensus. Where they converge and where emphasis differs:

WHO Classification of Tumours (5th ed, 2020) anchors the benign biology. Imaging-society guidance (ACR Appropriateness Criteria, ESR/European radiology consensus) drives the no-biopsy, no-surveillance approach for classic lesions. Spine-oncology consensus (e.g. AO Spine, Acosta/UCSF framework) governs the graded intervention ladder.

Registry and Resource Considerations

• No arthroplasty-style registry tracks hemangioma; evidence rests on institutional series (Mayo, UCSF, Pitie-Salpetriere) and the German multicenter radiotherapy cohort
• High-resource settings: Interventional radiology enables preoperative or stand-alone transarterial/alcohol embolization and vertebroplasty, shifting many aggressive epidural cases away from open surgery
• Limited-resource settings: Where embolization and cell-salvage are unavailable, open surgery for vascular lesions carries higher haemorrhage risk; radiotherapy (widely available, dose at least 34 Gy) becomes a key first-line option for painful lesions, and conservative observation is emphasised for incidental findings
• MDT coordination between spine surgeon and interventional radiologist is the practice standard wherever embolization is offered

• Surveillance of "atypical" but asymptomatic lesions: Low-T1 (fat-poor) lesions can look worrying yet behave indolently. There is no consensus on whether to image-monitor a fat-poor lesion without Laredo aggressive features; most authors observe, but interval MRI is sometimes used.
• Vertebroplasty alone for aggressive epidural lesions: Cementoplasty (with or without alcohol embolization) controls pain and sensory symptoms durably, but is unreliable for motor deficit. The threshold for choosing percutaneous treatment over open decompression in patients with mild myelopathy is debated.
• Embolization technique and timing: Particulate transarterial embolization 24-48 hours preoperatively is standard, but direct intralesional alcohol/Onyx and the optimal interval are not standardised, and radicular feeders raise spinal-cord-infarction concerns.
• Adjuvant radiotherapy after subtotal resection: Historical data show recurrence with under-dosed radiotherapy; the role of routine postoperative radiotherapy after modern gross-total or near-total resection is unsettled, and long-term radiation risk must be weighed in young patients.
• Pregnancy-associated enlargement: The reported rapid growth and regression of vertebral hemangiomas in pregnancy is based on case reports; the true magnitude of estrogen sensitivity and how aggressively to intervene during pregnancy remain uncertain.
• Biopsy safety: Bright-T1/T2 classic lesions need no biopsy, but when imaging is atypical the bleeding risk of percutaneous biopsy of a vascular lesion versus the need to exclude angiosarcoma is a genuine trade-off.

Hemangioma of bone is a benign vascular tumor most common in vertebral bodies (28%) and skull (20%), typically incidental in adults 40-60 years with 2:1 female predominance. Pathognomonic MRI shows bright T1 AND bright T2 signal (fat content). Radiographs show corduroy pattern in spine, sunburst in skull. 95%+ are asymptomatic requiring observation only. Symptomatic lesions may require radiotherapy, vertebroplasty, or surgery with preoperative embolization. Malignant transformation does NOT occur.